1,25D3 reduces prostate cancer cell invasion by suppressing the expression of MMP-9 and cathepsins and promoting the activity of tissue inhibitors of metalloproteinase-1 (TIMP-1) [15]. The gene discussed is MMP9; the disease is prostate carcinoma.